Winner 2020 Award Lecture-Hans Lennernäs, PhD. Professor in biopharmaceutics Department of pharmaceutical bioscience and technology,Uppsala university
PROFESSOR LENNERNAS WILL PRESENT THE LECTURE AT PHARMSCI 2021.
His research objectives has been and are to develop novel strategies of tissue drug targeting and delivery that is expected to improve the clinical use and efficacy of drugs in various diseases, such as metabolic and cancer diseases. He has been the Principal Investigator in an extensive collaboration with Food Drug & Administration, USA, University of Michigan, USA, and Medical Product Agency, Sweden during 1992-2000 to develop the novel FDA regulatory guideline named the Biopharmaceutics Classification System. He has established an extensive human pharmacokinetic database with jejunal permeability values for 45 drug compounds that today is widely used in academia and pharmaceutical industry. Prof. Lennernäs has been the chairman for numerous international conferences. He serves as reviewer for several scientific journals in clinical pharmacology and pharmaceutical science with a focus on drug delivery and pharmacokinetics
The APS Award Lecture is sponsored by Astra Zeneca and invites pharmaceutical scientists who are a member of the APS to nominate researchers from across the globe in academia, industry, public service or other scientific establishments.
The individual nominated should have demonstrated, scientific contribution where work should be outstanding and ambassadorial in their area with an international reputation and have a broad scientific awareness
Innovative Science Award Winner 2020-Professor Ryan F. Donnelly, Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast.
PROFESSOR DONNELLY WILL PRESENT HIS LECTURE AT PHARMSCI 2021
Professor Ryan Donnelly is a registered pharmacist. He holds the Chair in Pharmaceutical Technology in the School of Pharmacy at Queen’s University Belfast and is Director of the university’s interdisciplinary research programme Materials & Advanced Technologies for Healthcare, comprising 58 academics from Pharmacy, Chemistry & Chemical Engineering, Mechanical & Aerospace Engineering, Biological Sciences, Nursing and Medicine. His personal research is centred on design and physicochemical characterisation of advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, with a strong emphasis on improving patient outcomes. He is currently developing a range of novel microneedle technologies through independent research, but also in collaboration with several major pharma partners. He has obtained substantial Research Council, charity and industrial funding and authored over 400 peer-reviewed publications.
Professor Donnelly is Communications Chair of the Controlled Release Society and Europe/Africa Editor of Drug Delivery & Translational Research. His work has attracted numerous awards, including Evonik’s Resomer Award (2018), the Controlled Release Society’s Young Investigator Award (2016), BBSRC Innovator of the Year and the American Association of Pharmaceutical Scientists Pharmaceutical Research Meritorious Manuscript Award (2013), the GSK Emerging Scientist Award (2012) and the Royal Pharmaceutical Society’s Science Award (2011).
The Academy of Pharmaceutical Sciences present the Innovative Science Award sponsored by GlaxoSmithKline at PharmSci and invite pharmaceutical scientists to submit an application.
Entrants are welcome from researchers from across the globe in academia, industry, public service or other scientific establishments. The individual applicant should have demonstrated, through published work, a significant innovation which has the potential for application within the pharmaceutical industry.
Winner 2020-Dr Luis M Bimbo, Chancellor’s Research Fellow & Lecturer in Drug Delivery Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
DR BIMBO WILL PRESENT HIS LECTURE AT PHARMSCI 2021
Luis M. Bimbo is a Chancellor’s Research Fellow and Lecturer in Drug Delivery at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK, having graduated as a pharmacist from the University of Coimbra, Portugal in 2006, and completed an MRes in Cell Biology from the same university in 2010. He then undertook a PhD in Pharmaceutical Technology at the University of Helsinki, Finland, defending his thesis (with Distinction) in 2012. His PhD Thesis garnered several national and international awards including the 2012 Best Thesis Award from the Viikki Research Group Organization, which comprises all Biosciences except Medicine, and the 2014 International Award for the Most Outstanding Doctoral Thesis in the Pharmaceutical Sciences by the APV.
He is also the recipient of the 2012 Albert Wuokko Award to a Young Researcher from the Finnish Pharmaceutical Society (Finland’s most prestigious pharmaceutical award to a young researcher) and the 2015 Young Researcher Award from the Faculty of Pharmacy, University of Helsinki, Finland. In addition, he was conferred the title of Docent in Pharmaceutical Nanotechnology (equivalent to Adjunct Professor) at the University of Helsinki, Finland. His research group focuses on developing novel engineered materials for advanced drug delivery systems, such as porous silicon and porous polymers, supramolecular hydrogels, and drug nanocrystals, which so far attracted over £420,000 in external funding and resulted in 20 international peer-reviewed original research publications.
The award recognises researchers from across the globe in academia, industry, public service or other scientific establishments with no more than 10 years since award of their PhD, have an outstanding track record (for this stage of their career) indicative of excellent potential.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.